Mode
Text Size
Log in / Sign up

Can a machine learning model predict if I have lymph node metastasis in my papillary thyroid carcinoma?

high confidence  ·  Last reviewed May 15, 2026

Lymph node metastasis (LNM) is common in papillary thyroid carcinoma (PTC) and affects treatment decisions. Preoperative prediction of LNM can help avoid unnecessary surgery. Several machine learning (ML) models have been developed to predict LNM using different types of data, including ultrasound features, blood tests, CT scans, and genetic markers. These models show promising accuracy, but they are not yet standard clinical tools. Your doctor can help interpret these models in your specific case.

What the research says

Multiple studies have developed and validated ML models for predicting LNM in PTC. One model using clinical and ultrasound features along with inflammatory markers achieved an AUC of 0.830 in predicting central lymph node metastasis in patients with clinically node-negative T1-T2 PTC 1. Another deep learning model using preoperative CT images (ThyLNT) showed robust performance across multiple hospitals, with AUCs ranging from 0.80 to 0.90 6. A gene expression-based model using three key genes (RPS4Y1, PKHD1L1, CRABP1) achieved an AUROC of 0.992 in training and 0.911-0.953 in external validation 10. Additionally, a multi-modal model integrating histopathology images, genomic, and transcriptomic data predicted LNM with high accuracy 8. A separate study identified a 13-gene signature from single-cell RNA sequencing data that predicted LNM 9. These models use different types of data, but all show that ML can effectively predict LNM in PTC.

What to ask your doctor

  • Based on my ultrasound and blood test results, what is my estimated risk of lymph node metastasis?
  • Are there any machine learning models or nomograms available at your center to help predict lymph node spread?
  • Would additional tests like CT scans or genetic markers improve the prediction for my case?
  • How would knowing my lymph node metastasis risk change my treatment plan (e.g., extent of surgery)?
  • What are the limitations of current prediction models for my specific type of PTC?

This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.